VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 👀👏 Insiders buy on the market they think its going up🚀

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Jul 04, 2024 12:33pm

69 Views

Post# 36118319

👀👏 Insiders buy on the market they think its going up🚀

Now 0.21$ Insiders buy on the one market for one reason, they think its going up V4.0 FDA,Sales,Ascend Cardiovascular news! at any time

11:37 R 0,21 0,005 0,205 0,215 500 / 5 500 8,07k 0,21 0,205

Recent filings
Filed 2024-07-04 09:29 Tx date 2024-02-01	$VPT Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)	Hendriks, Bart 5 - Senior Officer of Issuer Direct Ownership	Debentures 00 - Opening Balance-Initial SEDI Report		$36
Filed 2024-07-02 17:46 Tx date 2024-06-28	$VPT Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)	MacNaught, Hugh 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Debentures 16 - Acquisition or disposition under a prospectus exemption	$ +$12 vol $1,000 each	$12
Filed 2024-07-02 17:44 Tx date 2020-09-30	$VPT Ventripoint Diagnostics Ltd. (formerly Luca Capital Inc.)	MacNaught, Hugh 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Debentures 00 - Opening Balance-Initial SEDI Report